Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FQ90X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,385
Award facts
- Contract value 100% obligated
- $15,385.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors, with a contract ceiling value of $15,385.14 and an ultimate completion date of September 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, has been selected to deliver this medication as part of its extensive federal medical procurement portfolio serving military and veteran healthcare systems. The delivery of Dupixent, a prescription medication used primarily for inflammatory conditions, demonstrates the company's capability to supply specialized brand-name pharmaceuticals through the DLA's medical supply chain. This award reflects AmerisourceBergen's established track record of fulfilling federal medical supply needs through open competition and its role as a critical vendor supporting Defense Health Agency operations and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQ90X?
SPE2DB25FQ90X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FQ90X worth?
The government has obligated $15,385 on SPE2DB25FQ90X.
Is contract SPE2DB25FQ90X an order under another contract?
Yes. SPE2DB25FQ90X is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ90X competed?
The extent of competition for SPE2DB25FQ90X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award